A Thorough QTc Evaluation of the Effect of Liraglutide on Cardiac Repolarization in Healthy Volunteers: A Randomized, Double-blind, Placebo-controlled, Two Period Crossover Study Followed by Open-label Moxifloxacin (Positive Control) Administration
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Liraglutide (Primary) ; Moxifloxacin
- Indications Bacterial infections; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 24 Jan 2012 Actual number of patients changed from 51 to 64 as reported by ClinicalTrials.gov.
- 24 Jan 2012 New source identified and integrated (ClinicalTrials.gov record NCT01516255)
- 05 Nov 2010 New trial record.